Option chain shows key data for Kindly MD's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kindly MD.

Kindly MD (NASDAQ:KDLY) Stock, Option Chain

Kindly MD

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Screen Shot 2024-10-31 at 11.47.29

Cannabis

News

Health Care

Events

Markets

General

KDLY

Leaders explore patient access and loyalty in the wellness cannabis market, challenges, adult-use impacts, and more at Benzinga&#39;s CCC

Ricky Williams And Wellness Experts Discuss Strategies For Cannabis Patient-Centric Care

movers image

Pre-Market Outlook

Movers

Trading Ideas

AEHR

AKAN

AMLI

CETX

CMND

CTCX

GLXG

GRTS

JTAI

LILM

LKCO

LUXH

MLGO

MNTS

NIVF

TSLA

ZENA

Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

AIEV

BENF

CLOV

GHSI

GLMD

MOBX

NTBL

NXPL

QMCO

REVB

ROMA

SNOW

STAF

STEC

URBN

VRAX

WOLF

Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Kindly MD Inc

Eric Jackson, the founder and portfolio manager at EMJ Capital, has shared his thoughts on the potential catalysts that could drive Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) value to $100,000.
What Happened: On Friday, Jackson appeared on CNBC&#8217;s Closing Bell and suggested that the upcoming Thanksgiving holiday, new SEC policies, and global adoption could spark Bitcoin&#8217;s next bull run.
During the interview, Jackson stated, &#8220;I think a lot of people that I talk to say, well, it&#8217;s just going to kiss $100,000 and pull back.&#8221;&nbsp;
Adding, &#8220;But I do think there&#8217;s a chance like that $100,000 milestone could be a rethink for a lot of investors both institutional, sovereign retail, and there are a bunch of catalysts ahead I think.&#8221;
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42052184/will-shiba-inu-coin-reach-1-cent-by-2025-47-of-benzinga-readers-say?itm_source=parsely-api">Will Shiba Inu Coin Reach 1 Cent By 2025? 47% Of Benzinga Readers Say…</a>
He went on to explain that the new SEC regime and the potential for a strategic reserve could be significant catalysts for Bitcoin.
Jackson also said that the Thanksgiving period often acts as a springboard for bullish crypto periods, rather than a setback.
He concluded by saying, &#8220;I think those names, you know, and the fact that they … there&#8217;s a real structure that&#8217;s going to be coming into place, around crypto and Bitcoin, I think those will be catalysts in and of themselves.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> hitting an all-time high again today on the path to $100K. How much longer can the supportive action continue? <a href="https://twitter.com/ericjackson?ref_src=twsrc%5Etfw">@EricJackson</a> discusses:<a href="https://t.co/Z3PZanYx4F">https://t.co/Z3PZanYx4F</a>
&mdash; CNBC&#39;s Closing Bell (@CNBCClosingBell) <a href="https://twitter.com/CNBCClosingBell/status/1860091069284962733?ref_src=twsrc%5Etfw">November 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Earlier, Galaxy Digital Holdings Ltd. CEO Mike Novogratz warned of a potential pullback due to excessive market leverage, but maintained that Bitcoin <a href="https://www.benzinga.com/24/11/42130693/bitcoins-path-to-100k-inevitable-but-leverage-to-the-gills-warns-mike-novogratz-predicts-80k-correction-ahead">reaching $100,000 is &#8220;inevitable.&#8221;</a>
Meanwhile, MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) executive chairman Michael Saylor has predicted that Bitcoin could hit $13 million by 2045, a valuation that would put Bitcoin's market <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42116183/michael-saylor-predicted-bitcoin-to-hit-13-million-if-it-happens-it-will-entail-massive-hyperinflation-analyst-warns">cap at around $250 trillion</a>.
Companies like MicroStrategy, which <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42121936/bitcoin-boom-20-microstrategy-gains-traction-as-a-leveraged-bet-on-crypto-growth">owns more than 150,000 Bitcoins</a>, are emerging as key players in this evolving market, effectively operating as a leveraged bet on the cryptocurrency.
In a note to Benzinga, Sumit Gupta, co-founder of CoinDCX, highlighted the surge in <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42135905/bitcoin-nears-100000-momentum-could-continue-well-beyond-the-milestone-experts-note">trading activity as a key driver</a>. He also pointed to developments in the U.S. political landscape as a contributing factor.
The digital asset market has already benefited from the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42131449/with-gary-gensler-preparing-to-quit-in-2025-secs-crypto-cases-likely-to-quietly-go-away-amid-trumps-pro-bitcoin-stance-says-pantera-capitals-katrina-paglia">incoming administration</a> of President-elect Donald Trump, with many speculating that a potential second term could bring more favorable regulatory policies for crypto.
Gupta added that speculation over SEC Chair Gary Gensler's resignation and the possibility of crypto-friendly leadership has further fueled investor optimism.
Price Action: At the time of writing, Bitcoin was trading at $98,816, up nearly 0.2% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/education/24/11/42098422/heres-how-much-100-invested-in-cardano-today-could-be-worth-if-ada-hits-new-all-time-highs?itm_source=parsely-api">Here&#8217;s How Much $100 Invested In Cardano Today Could Be Worth If ADA Hits New All-Time Highs</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Pixabay

Analyst Color

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSTR

Bitcoin's Road To $100K: Why Thanksgiving, New SEC Policies, And Global Adoption Could Spark The Next Bull Run, According To This Portfolio Manager

President-elect Donald Trump has picked hedge fund executive Scott Bessent as the U.S. Treasury Secretary.
What Happened: Bessent, 62 and founder of Key Square Group, was a leading candidate, <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42091821/could-donald-trumps-potential-treasury-secretary-be-out-of-his-depth-on-crypto-policy-polymarket-traders-just-cant-decide-on-a-favorite">competing with</a> former Fed Governor Kevin Warsh and private equity executive Marc Rowan.
While sharing the decision on Friday via his social media platform Truth Social, Trump lauded Bessent as "one of the World's foremost International Investors and Geopolitical and Economic Strategists."
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22205557/Screenshot-2024-11-23-at-7.25.49%E2%80%AFAM-900x1024.png" alt="" class="wp-image-661913" /><figcaption class="wp-element-caption">Source: Truth Social</figcaption></figure>
See Also: <a href="https://www.benzinga.com/news/legal/24/11/42147981/trumps-hush-money-sentencing-delayed-as-legal-immunity-debate-escalates">Trump&#8217;s Hush Money Sentencing Delayed As Legal Immunity Debate Escalates</a>
Bessent is known for his support of gradual tariffs and deregulation, aligning with Trump&#8217;s economic vision, which includes reviving manufacturing and achieving energy independence.
Despite his previous role as chief investment officer for George Soros' fund, Trump expressed confidence in Bessent&#8217;s ability to improve U.S. competitiveness and address trade imbalances.
Why It Matters: As Treasury Secretary, Bessent will replace outgoing Secretary Janet Yellen, overseeing financial institutions and combating financial crimes at a time when <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42140842/sp-500-faces-volatile-2025-as-inflation-boom-could-return-bank-of-america-strategist">the national debt has ballooned to $36 trillion</a>.
According to <a href="https://www.benzinga.com/government/regulations/24/11/41909846/trumps-treasury-pick-frontrunner-scott-bessent-could-shift-wall-street-crypto">betting markets</a>, Bessent was a frontrunner with an 82% probability of securing the nomination. His appointment could significantly impact Wall Street and the crypto sector.
In October, Bessent assured that a new Trump administration would <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41308042/trump-adviser-defends-ex-presidents-economic-policies-strong-dollar-would-natural">support a strong dollar</a>, countering previous suggestions of a weaker dollar to boost exports.
Despite Elon Musk&#8217;s support for Howard Lutnick, <a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks">Trump favored Bessent&#8217;s</a> business-as-usual approach.
In July, Bessent gained attention for his optimistic stance on cryptocurrency, suggesting he might support digital assets if confirmed. &#8220;Crypto is about freedom and the crypto economy is here to stay,&#8221; he stated at the time.
The latest 13F filing from Bessent&#8217;s Key Square Group fund shows a highly concentrated portfolio, with equal investments in two banking-focused ETFs: the SPDR S&amp;P Regional Banking ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRE#NYSE">KRE</a>) and the SPDR S&amp;P Bank ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBE#NYSE">KBE</a>), each making up 50% of the fund.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42146895/are-you-rich-enough-to-benefit-from-trumps-tax-breaks-heres-how-much-youd-need-to-be-part-of-the-top-5">Are You Rich Enough To Benefit From Trump&#8217;s Tax Breaks? Here&#8217;s How Much You&#8217;d Need To Be Part Of The Top 5%</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Government

Regulations

Politics

Economics

Trump Picks Hedge Fund Exec Scott Bessent As Treasury Secretary: What President-Elect's Choice Means For America's Economic Future

APLMW

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

APLM

UBS analyst Jay Sole maintains Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) with a Sell and raises the price target from $14 to $16.

Price Target

Analyst Ratings

UBS Maintains Sell on Gap, Raises Price Target to $16

UBS analyst Mark Carden maintains BJ's Wholesale Club (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) with a Buy and raises the price target from $102 to $108.

UBS Maintains Buy on BJ's Wholesale Club, Raises Price Target to $108

UBS analyst Steven Fisher maintains Deere (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) with a Neutral and raises the price target from $404 to $462.

UBS Maintains Neutral on Deere, Raises Price Target to $462

UBS analyst Karl Keirstead maintains Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Neutral and raises the price target from $275 to $360.

UBS Maintains Neutral on Salesforce, Raises Price Target to $360

Jefferies analyst Lloyd Byrne maintains Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) with a Hold and raises the price target from $12 to $22.

Jefferies Maintains Hold on Bloom Energy, Raises Price Target to $22

Jefferies analyst Jonathan Petersen maintains SL Green Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLG#NYSE">SLG</a>) with a Hold and raises the price target from $70 to $72.

Jefferies Maintains Hold on SL Green Realty, Raises Price Target to $72

Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the "Form 10-Q"), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the "SEC").
Ocean Biomedical is delayed in filing the Form 10-Q as a result of previously disclosed developments with respect to filing of its 10-K for the year ended December 31, 2023.
The current notice will have no immediate effect on the listing or trading of Ocean Biomedical's common stock on Nasdaq, although there can be no assurances that further delays in the filing of the Form 10-Q will not have an impact on the listing or trading of the company's common stock. On October 16, 2024, Staff notified the Company that since it failed to timely file its Form 10-K for the year ended December 31, 2023, and its Forms 10-Q for the periods ended March 31, 2024 and June 30, 2024, the Company's securities were subject to delisting. The Company is now delinquent in the filing its form 10-Q for the period ended September 30, 2024. Accordingly, this matter serves as an additional basis for delisting the Company's securities from The Nasdaq Stock Market. This is formal notification that the Nasdaq Hearings Panel (the "Panel") will consider this matter in their decision regarding the Company's continued listing on The Nasdaq Capital Market, which hearing is scheduled for December 16, 2024. The Company intends to file the delinquent Forms 10-Q and 10-K as soon as practicable.

OCEA

Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report

DA Davidson analyst Gil Luria maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Neutral and raises the price target from $60 to $70.

PCOR

DA Davidson Maintains Neutral on Procore Technologies, Raises Price Target to $70

Chesapeake Utilities Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPK#NYSE">CPK</a>) ("Chesapeake Utilities" or the "Company") today announced that it has established an at-the-market equity offering program (the "ATM Program") under which it may, from time to time, sell shares of its common stock having an aggregate sales price of up to $100,000,000 (the "Shares"). Chesapeake Utilities has entered into an equity distribution agreement with each of RBC Capital Markets, LLC, Barclays Capital Inc., Janney Montgomery Scott LLC, Ladenburg Thalmann &amp; Co. Inc., Guggenheim Securities, LLC, Citizens JMP Securities, LLC, M&amp;T Securities, Inc., Maxim Group LLC, PNC Capital Markets LLC, and Siebert Williams Shank &amp; Co., LLC (collectively, the "Sales Agents"), as sales agents. Pursuant to the equity distribution agreement, sales of the Shares may be made in transactions deemed to be "at-the-market offerings," as defined in Rule 415 under the Securities Act of 1933, as amended, including by sales made directly on or through the New York Stock Exchange. Chesapeake Utilities intends to use the proceeds from the sales, if any, of the Shares for general corporate purposes, including, but not limited to, financing of capital expenditures, repayment of short-term debt, financing acquisitions, investing in subsidiaries, and general working capital purposes.

Offerings

Chesapeake Utilities Corporation Announces $100M At-The-Market Equity Offering Program

DA Davidson analyst Gil Luria maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Neutral and raises the price target from $90 to $135.

NVDA

DA Davidson Maintains Neutral on NVIDIA, Raises Price Target to $135

DA Davidson analyst Gil Luria maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Neutral and raises the price target from $75 to $115.

ESTC

DA Davidson Maintains Neutral on Elastic, Raises Price Target to $115

<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42131449/with-gary-gensler-preparing-to-quit-in-2025-secs-crypto-cases-likely-to-quietly-go-away-amid-trumps-pro-bitcoin-stance-says-pantera-capitals-katrina-paglia">President-elect Donald Trump</a> needs to find someone else to replace US Securities and Exchange Commission chair Gary Gensler. 
The Details: According to <a href="https://www.bloomberg.com/news/articles/2024-11-22/robinhood-s-gallagher-drops-out-of-sec-chair-consideration?sref=TBDibEcD">Bloomberg</a>, Dan Gallagher, chief legal officer at Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) has removed himself from consideration as head of the SEC.
Gallagher expressed his intention to remain at Robinhood in an emailed statement. 
&#8220;It is always an honor to have your name in the mix for an incredibly important job like SEC Chairman. However, I have made it clear that I do not wish to be considered for this position,&#8221; Gallagher said.&nbsp;
&#8220;I am committed to Robinhood and our millions of customers who represent the new generation of retail investors.&#8221;
Read More: <a href="https://www.benzinga.com/general/social-media/24/11/42119493/rumble-eyes-buying-bitcoin-could-it-be-the-next-microstrategy">Rumble CEO Considers Bitcoin Investment, Engages Michael Saylor As Shares Rally</a>
Gallagher has been Robinhood's chief legal officer since 2020. He steered the company through the GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) meme stock saga and Trump considered him a top <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41212008/trump-considers-robinhood-exec-dan-gallagher-for-sec-chair-if-re-elected">contender for the position</a>. He was a Republican SEC commissioner from 2011 to 2015, and previously served in other senior roles in the agency. 
The crypto community favored Gallagher, feeling he would <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41876266/bitcoin-blasts-past-82000-buy-everything-you-can-says-bernstein">help to advance</a> pro-crypto regulatory change.
Among the other names being floated for SEC chair include: Robert Stebbins, the SEC's former general counsel; Paul Atkins, former SEC commissioner; and Brian Brooks, former <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42053981/trump-sec-pick-speculation-sends-this-altcoin-soaring-past-bitcoin-and-ethereum-in-daily-gains">cryptocurrency executive</a> and former acting comptroller of the currency. 
As for Gallagher, he will stay on as head legal counsel at Robinhood.&nbsp;
"I will remain a vocal and consistent advocate for positive change in our markets,&#8221; Gallagher said. He added that he is &#8220;excited to work with the incoming Trump Administration, including the next SEC Chairman and the SEC staff, to promote innovation and provide more opportunity for retail investors.&#8221;
Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Robinhood shares ended Friday's session up 4.45% at $36.65. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a></li>
</ul>
Image: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Legal

HOOD

MKTX

Robinhood's Gallagher Bows Out Of SEC Chair Consideration Under Incoming Trump Administration

Jefferies analyst Omar Nokta maintains Navigator Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVGS#NYSE">NVGS</a>) with a Buy and maintains $20 price target.

NVGS

Jefferies Maintains Buy on Navigator Holdings, Maintains $20 Price Target

Despite widespread anticipation that NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)'s quarterly results would dictate Wall Street's year-end trajectory, the stock market delivered a robust weekly rebound — even in the absence <a href="https://www.benzinga.com/quote/NVDA/news">of its AI darling.</a>
While the semiconductor titan beat analyst expectations on both earnings and revenue for the third quarter, Nvidia's stock remained flat for the week.
Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), the parent company of Google, faced sharp turbulence. Shares tumbled after the U.S. Department of Justice called for the divestiture of Chrome in a bid to curb Google's dominance in search and digital advertising.
The sell-off wiped out over $120 billion in market capitalization on Thursday alone.
A <a href="https://www.benzinga.com/tech/24/11/42140450/doj-targets-google-chrome-poll-shows-64-oppose-alphabet-breakup-youtube-seen-as-top-prize">recent Benzinga poll indicates</a> 64% of respondents oppose breaking up Alphabet, with YouTube viewed as the company's most valuable asset.
On the economic front, <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42141413/us-business-activity-soars-to-31-month-highs-in-november-small-caps-rally-dow-tops-44000">U.S. private sector activity expanded significantly</a> in November, as reflected in S&amp;P Global's Purchasing Managers' Index surveys. The services sector, in particular, surged at its fastest pace since March 2022, while price pressures continued to recede, creating less headwinds for the Federal Reserve.
Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rally shows no signs of cooling, with the cryptocurrency notching its fourth consecutive week of gains and hovering around the <a href="https://www.benzinga.com/24/11/42130693/bitcoins-path-to-100k-inevitable-but-leverage-to-the-gills-warns-mike-novogratz-predicts-80k-correction-ahead">historic $100,000 threshold.</a>
The U.S. dollar also maintained its upward momentum, rising for the eighth straight week to <a href="https://www.benzinga.com/news/econ-s/24/11/42138717/dollar-hits-2-year-highs-as-europes-recession-signals-spark-euro-pound-sell-offs">reach two-year highs.</a> This latest rally, however, stemmed largely from external turmoil, as escalating geopolitical tensions between Russia and Ukraine, coupled with worsening economic momentum in Europe, triggered sharp weekly sell-offs in the euro and the British pound.
<h1 class="wp-block-heading">You might have missed…</h1>
<h1 class="wp-block-heading">Trump Backs Drilling</h1>
President-elect Donald Trump advocates for increased fossil fuel production with his &#8220;drill, baby, drill&#8221; policy. In contrast, Elon Musk, co-leader of the proposed Department of Government Efficiency (DOGE), envisions a future dominated by solar energy. UBS analysts recommend investors consider renewable energy stocks following their <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42130859/as-trump-backs-drill-baby-drill-his-doge-co-lead-elon-musk-believes-all-energy-generation-will-be-solar-heres-what-ubs-recommends-after-election-dip">election-induced market dip.</a>
<h1 class="wp-block-heading">Trump Crypto Clarity</h1>
Cathie Wood of Ark Invest anticipates the Trump administration will provide regulatory clarity for Bitcoin and other digital assets, potentially incorporating them into <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42136536/ark-invests-cathie-wood-says-team-trump-would-give-regulatory-clarity-for-bitcoin-and-other-digital-assets-which-they-may-put-in-the-treasurys-strategic-reserve">the Treasury&#8217;s strategic reserve</a>.
<h1 class="wp-block-heading">GM Eyes F1</h1>
General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) is reportedly preparing to enter Formula One in 2026, potentially partnering with Andretti Autosport. This move would mark GM&#8217;s first foray into F1, aligning with its global <a href="https://www.benzinga.com/24/11/42135392/general-motors-gears-up-for-potential-f1-entry-in-2026-report">motorsport expansion strategy.</a>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42137929/2025-us-economy-outlook-cloudier-than-normal-jpmorgan-says-boom-bust-scenarios">2025 US Economy Outlook &#8216;Cloudier Than Normal,&#8217; JPMorgan Says: Boom, Bust Scenarios</a></li>
</ul>
Photo: Shutterstock

Large Cap

Forex

Global

Tech

GOOG

GOOGL

Wall Street Rebounds Without Its AI Darling's Boost, King Dollar Maintains Dominance While Bitcoin Defies Gravity: This Week In The Markets

Rosenblatt analyst Catharine Trebnick maintains Zoom Video Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) with a Buy and maintains $78 price target.

Rosenblatt Maintains Buy on Zoom Video Comms, Maintains $78 Price Target

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Though Reddit (NYSE:<a href="https://investorplace.com/stock-quotes/rddt-stock-quote/">RDDT</a>) may have been the most recent big-name IPO, the initial listings market is still cooking, and undervalued IPO stocks abound. The last undervalued IPO stock I picked at the <a href="https://investorplace.com/2024/06/penny-stocks-that-pack-a-punch-3-names-to-ride-for-10x-gains/">beginning of June,</a> Nano Nuclear Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/nne-stock-quote/">NNE</a>), returned over 300% since I first noticed it, further proving that undervalued IPO stocks are out there if you know where to look.



In general, the wider IPO market is improving as the year&rsquo;s first half saw <a href="https://www.ey.com/en_gl/insights/ipo/trends">86 U.S.-based IPOs</a> raise nearly $18 billion, a 12% and 67% improvement, respectively, compared to 2024&rsquo;s first half. That does, of course, still pale compared to 2021&rsquo;s shockingly high IPO rates that raised more than $450 globally, but still far better than last year as economic conditions soften. This, of course, benefits undervalued IPO stocks as many still shy away from their inherent &ldquo;opening day&rdquo; risk. These undervalued IPOs often fly under the radar as investors focus primarily on tech and mega-caps &mdash; but that doesn&rsquo;t detract from their long-term upside.



<h2>Viking Holdings (VIK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/04/vik1600-300x169.png" alt="MV Viking Star in North Sea Canal. Detail of funnel. VIK stock and VIK IPO"><div>Source: StudioPortoSabbia / Shutterstock.com</div></div>Viking Holdings (NYSE:<a href="https://investorplace.com/stock-quotes/vik-stock-quote/">VIK</a>) is an undervalued IPO stock operating within a segment that&rsquo;s been beaten down in recent years but is due for a resurgence: luxury cruising and passenger transport. The cruise liner stock accomplishes this with a fleet of almost 100 small, high-tech ships. Viking is the largest undervalued IPO stock on our list at a $14.35 billion market cap and the company&rsquo;s shares jumped nearly 40% since first listing in May.



The company&rsquo;s <a href="https://d1io3yog0oux5.cloudfront.net/_d2eabbad631141770d0deb474fe836e3/vikingcruises/db/947/9193/presentation/Earnings+Presentation.pdf">waterborne operations</a> primarily focus on river boating, with 80 existing vessels and 18 more to be delivered in the next two years. But Viking is increasing its oceanic presence and will augment its existing nine seafaring ships with eight more by the end of the decade. Viking seeks to differentiate itself from most cruise liners, which emphasizes partying and ship-centric activities rather than destination arrival. A generally youth-skewing crowd says that &ldquo;Vikings are contrarians, and hence, from the beginning, the vision has been to build a different cruise line.&rdquo; This led Viking to emphasize &ldquo;quiet, understated elegance&rdquo; and a destination focus that targets older demographics of 55+.



Viking&rsquo;s financials already point to a sector-wide turnaround, with revenue improving 14% year-over-year between the first quarters of 2024 and 2023. Expect these tailwinds to continue as the undervalued IPO stock sets sail.



<h2>Proficient Auto Logistics (PAL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/10/danaos-dac-shipping-transportation-1600-300x169.jpg" alt="A photo of a large shipping vessel at sea."><div>Source: Daniel Wright98 / Shutterstock.com</div></div>Proficient Auto Logistics (NASDAQ:<a href="https://investorplace.com/stock-quotes/pal-stock-quote/">PAL</a>) operates within a logistics and transportation segment that&rsquo;s nearly impossible to replace or substitute: vehicular transport, as in the type that brings cars from manufacturers to dealerships, ports and railyards. The company&rsquo;s IPO is unique in that it was a merger of five existing companies under a single umbrella that went public, with shares climbing about 8% since the IPO.



Proficient Auto&rsquo;s <a href="https://proficientautologistics.com/investor-relations/">customer list</a> is a who&rsquo;s who of manufacturers and includes Tesla (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>), General Motors (NYSE:<a href="https://investorplace.com/stock-quotes/gm-stock-quote/">GM</a>), Stellantis (NYSE:<a href="https://investorplace.com/stock-quotes/stla-stock-quote/">STLA</a>) and Rivian (NASDAQ:<a href="https://investorplace.com/stock-quotes/rivn-stock-quote/">RIVN</a>). Though some car manufacturers, like Tesla, prefer to vertically integrate their value chain as much as possible, logistics of this type tends to be a bridge too far from a pricing and resource management perspective, so Proficient Auto has plenty of business in its future.



Proficient saw its net deliveries slump in 2023 amid labor strikes at General Motors and Stellantis and generally reduced consumer interest in car purchases. But that downward trend is already reversing as the company&rsquo;s total units delivered increased by 2% in this year&rsquo;s <a href="https://proficientautologistics.com/wp-content/uploads/2024/06/Earnings-Release-for-Website.pdf">first quarter</a> report &mdash; expect that upward momentum to continue throughout the year as Proficient realizes synergies it created through combining multiple companies and generally improving its own internal processes.



<h2>KindlyMD (KDLY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600-300x169.jpg" alt="Nurse holding a tablet with icons representing different aspects of healthcare and healthcare data representing CANO stock. Healthcare Tech Stocks. Healthcare Stocks to Buy"><div>Source: metamorworks / Shutterstock</div></div>I want to first acknowledge that, among these undervalued IPO stocks, KindlyMD (NASDAQ:<a href="https://investorplace.com/stock-quotes/kdly-stock-quote/">KDLY</a>) trades firmly in penny stock territory at less than $3 per share and a meager $15 million market cap. However, its small size makes KindlyMD&rsquo;s undervalued IPO prospects more appealing. The company operates at the forefront of two unique trends: medical cannabis, which is ready to boom, and <a href="https://kindlymd.com/about-us/">holistic treatments</a> that blend prescription medication, behavioral and mental therapy and alternative solutions that &ldquo;treat the whole person, not just their symptoms.&rdquo;



KindlyMD&rsquo;s first <a href="https://feeds.issuerdirect.com/news-release.html?newsid=8925359497374292">earnings report</a> came shortly after its IPO, and top-line numbers were considerably low at just $829,000 in revenue. But that slim sales stat is, practically speaking, a short-term hurdle toward long-term success. Specifically, KindlyMD hit a range of benchmarks that all but assure expansion and growth in the coming years. That includes becoming Utah&rsquo;s first alternative medicine company to contract under the state&rsquo;s insurance, including Medicare/Medicaid. It contracted with mega-insurer federation Blue Cross Blue Shield and secured 16% of Utah&rsquo;s current total addressable medical cannabis market. Better yet, for cannabis stock enthusiasts, KindlyMD and Curaleaf (OTCMKTS:<a href="https://investorplace.com/stock-quotes/curlf-stock-quote/">CURLF</a>) started a <a href="https://www.marketscreener.com/quote/stock/KINDLY-MD-INC-170748083/news/KindlyMD-Collaborates-with-Curaleaf-to-Expand-Patient-Education-on-Medical-Cannabis-Care-in-Utah-46945278/">collaboration</a> to expand awareness of alternative treatment opportunities throughout Utah.



On the date of publication, Jeremy Flint held no positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines.</a>



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Jeremy Flint, an MBA graduate and skilled finance writer, excels in content strategy for wealth managers and investment funds. Passionate about simplifying complex market concepts, he focuses on fixed-income investing, alternative investments, economic analysis, and the oil, gas, and utilities sectors. Jeremy&rsquo;s work can also be found at <a href="https://jeremyflint.work/">www.jeremyflint.work</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/07/3-ipo-gems-flying-under-the-radar-for-now/">3 IPO Gems Flying Under the Radar (for Now)</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

3 IPO Gems Flying Under the Radar (for Now)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
With the federal government moving to <a href="https://www.forbes.com/sites/dariosabaghi/2024/05/22/dea-publishes-proposed-rules-to-reschedule-marijuana/?sh=57e2057e48e8">reschedule</a> cannabis to Schedule III, effectively paving the way for medical cannabis legalization, <a href="https://investorplace.com/industries/healthcare/cannabis/">cannabis stocks</a> are in the spotlight. Cannabis stocks initially spiked on the news but quickly returned to previous levels. This tempered response reflects concerns about the potential disruption a medical cannabis mandate might bring, creating uncertainty that has made investors hesitant to commit to specific cannabis stocks at this moment. Still, tailwinds are gathering behind small and large cannabis stocks alike, creating a unique opportunity to capture upside as some cannabis stocks approach 52-week lows &mdash; or worse.



Ultimately, these cannabis stocks corner a unique segment in a crowded sector, creating an upside of their own based on fundamental and operational strength. Still, they&rsquo;ve fallen prey to wider uncertainty about cannabis stocks more broadly, even as they buck wider trends that include poor distribution channels, limited marketing opportunities and concerns surrounding banking.



<h2>Tilray&nbsp;(TLRY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/01/shutterstock_1904349628-300x169.png" alt="Closeup of mobile phone screen with logo lettering of cannabinoid company tilray cannabis, blurred marijuana and pipette background"><div>Source: Ralf Liebhold / Shutterstock.com</div></div>Tilray&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tlry-stock-quote/">TLRY</a>) shares rebounded slightly in recent weeks, but the company&rsquo;s per-share pricing still sits close to 52-week lows and even further from past highs pre-2020 when it traded north of $140. But stock suppression of this magnitude conceals Tilray&rsquo;s true long-term strength compared to other cannabis stocks.



One of those unique strengths is Tilray&rsquo;s expanding craft beer business. Since acquiring several brands from Anheuser-Busch (NYSE:<a href="https://investorplace.com/stock-quotes/bud-stock-quote/">BUD</a>) in 2023, Tilray <a href="https://www.bloomberg.com/news/articles/2024-01-09/craft-beer-growth-is-saving-tilray-from-cannabis-vegetable-woes">doubled its alcohol sales</a>, generating important sales diversification within the competitive cannabis market.



Tilray&rsquo;s craft beer forays are significant and often underestimated. As recreational cannabis legalization progresses through national legislative channels, Tilray&rsquo;s well-established production, distribution, and operational network positions it uniquely to capitalize on eventual legalization. Its newly bought infrastructure could be pivotal in distributing cannabis products nationwide and give Tilray a notable edge over competitors.



Tilray is building a $250 million cash reserve to <a href="https://investorplace.com/2024/06/is-tilray-stock-your-ticket-to-the-coming-u-s-cannabis-gold-rush/">fund strategic acquisitions</a> and expand its operations. While this move will dilute shares, it also creates further unique opportunities among cannabis stocks as Tilray builds and consolidates a US-based empire.



<h2>KindlyMD (KDLY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/04/cannabis-stocks1600-3-300x169.png" alt="scientist checking organic hemp wild plants in a cannabis weed commercial greenhouse. Concept of herbal alternative medicine, cbd oil, pharmaceutical industry. Cannabis stocks, FLGC stocks"><div>Source: Chokniti-Studio / Shutterstock.com</div></div>Including KindlyMD&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/kdly-stock-quote/">KDLY</a>) among cannabis stocks at 52-week lows is kind of cheating, as the company only just hit public markets. Still, shares have slid rapidly since IPO, dropping 22% from its initial $3 listing price. But the rapid downswing, as with Tilray, conceals KindlyMD&rsquo;s unique status amongst cannabis stocks.



KindlyMD is positioned at the intersection of two growing trends: the burgeoning medical cannabis sector and holistic treatments that integrate prescription medication with behavioral, mental therapy, and alternative solutions to &ldquo;<a href="https://kindlymd.com/about-us/">treat the whole person</a>, not just their symptoms.&rdquo;



Although its <a href="https://feeds.issuerdirect.com/news-release.html?newsid=8925359497374292">first earnings report</a> post-IPO showed a modest revenue of $829,000, this is more of a short-term challenge on the path to long-term success. The company has achieved several milestones that indicate significant potential for future growth. Notably, KindlyMD became Utah&rsquo;s first alternative medicine company to secure contracts under the state&rsquo;s insurance programs, including Medicare and Medicaid. It also signed a deal with Blue Cross Blue Shield and currently holds 16% of Utah&rsquo;s medical cannabis market.



<h2>Valley National Bancorp (VLY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/banks1600-300x169.jpg" alt="Image of a grey cityscape with a large corporate building that features the word bank on it"><div>Source: Shutterstock</div></div>As with KindlyMD, Valley National Bancorp&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/vly-stock-quote/">VLY</a>)&nbsp;sits at the intersection of two unique sectors: cannabis and banking. Both sectors are facing unique challenges, though, contributing to Valley National&rsquo;s current per-share pricing woes.



<a href="https://www.morningstar.com/stocks/xnas/vly/quote">Valley National trades</a> at a mere 0.6x book value and 8x earnings, making it both undervalued and often overlooked, considering its unique forays into <a href="https://www.retailbrew.com/series/spliff-and-mortar/stories/2023/03/30/dank-of-america-why-getting-dropped-by-a-bank-is-seen-as-a-rite-of-passage-for-cannabis-retailers">cannabis-based banking</a> as one of the few institutions happily servicing cannabis retailers. The bank&rsquo;s strong financial foundation is evident through its low <a href="https://www.morningstar.com/stocks/xnas/vly/valuation">debt-to-equity ratio</a> of just 0.56, significantly lower than the industry average of 1.2. This demonstrates Valley National&rsquo;s conservative leverage approach compared to its peers. Recent initiatives, such as the <a href="https://finance.yahoo.com/news/valley-national-vly-announces-share-161100413.html">stock buyback program</a> and a 6.07% <a href="https://www.morningstar.com/stocks/xnas/vly/dividends">trailing dividend yield</a>, further highlight the bank&rsquo;s robust financial health and commitment to returning value to shareholders.



<a href="https://equityset.com/stocks/nasdaq-vly?tag=stock-analysis&amp;tab=sentiment">Analysts also see potential</a> in Valley National, setting an average price target of $8.06, which is about 6% above its current share price. Sentiment around the bank stock is improving, with 56% of analysts now recommending a &ldquo;hold,&rdquo; a significant shift from the 50% who advised selling in the previous period. This positive momentum suggests a promising outlook for Valley National as an undervalued investment opportunity among cannabis stocks.



On the date of publication, Jeremy Flint held no positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the <a href="http://InvestorPlace.com">InvestorPlace.com</a> <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;
<div>Jeremy Flint, an MBA graduate and skilled finance writer, excels in content strategy for wealth managers and investment funds. Passionate about simplifying complex market concepts, he focuses on fixed-income investing, alternative investments, economic analysis, and the oil, gas, and utilities sectors. Jeremy&rsquo;s work can also be found at <a href="https://jeremyflint.work/">www.jeremyflint.work</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/07/3-cannabis-stocks-to-buy-at-a-52-week-low-in-july/">3 Cannabis Stocks to Buy at a 52-Week Low in July</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

3 Cannabis Stocks to Buy at a 52-Week Low in July

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Kindly MD (NASDAQ:<a href="https://investorplace.com/stock-quotes/kdly-stock-quote/">KDLY</a>) just reported results for the second quarter of 2024.<ul><li>Kindly MD reported earnings per share of -26 cents.</li><li>The company reported revenue of $639,057.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/kdly-stock-earnings-kindly-md-for-q2-of-2024/">KDLY Stock Earnings: Kindly MD Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

KDLY Stock Earnings: Kindly MD Reported Results for Q2 2024

KindlyMD GAAP EPS of -$0.26

Kindly MD, Inc. (KDLY) has provided an update. Kindly MD, Inc., a Utah-based company, is informing its investors and the broader investment communi...

Kindly MD, Inc. Embraces Social Media for Investor Updates

Kindly MD, Inc. ( ($KDLY) ) just unveiled an announcement. KindlyMD, a healthcare company focusing on integrated medical strategies, has launched a...

Kindly MD, Inc. Announces Stock Repurchase Program

Kindly MD, Inc. ( ($KDLY) ) has provided an announcement. Tim Pickett, CEO of Kindly MD, Inc., is presenting at the LD Micro Conference, sharing in...

Kindly MD CEO Presents at LD Micro Conference

KindlyMD (KDLY) is now contracted with Cigna (CI) Healthcare, after receiving additional credentialing. Cigna's innovative approach to behavioral h...

KindlyMD enters partnership with Cigna Healthcare

Reports Q3 revenue $647,867 vs. $869,268 last year. "We are pleased with the progress made during the third quarter to expand our credentialing and...

KindlyMD reports Q3 EPS (17c) vs. (11c) last year

KindlyMD GAAP EPS of -$0.17, revenue of $0.65M

CURLF

RDDT

RIVN

STLA

TLRY

Press Releases

KindlyMD to Present at Upcoming August 2024 Investor Conferences

Earnings

KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update

Management

KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director

KindlyMD to Participate in H.C. Wainwright's 26th Annual Global Investment Conference on September 9-11, 2024

KindlyMD(TM) Recognized with Healthcare AI Impact Award 2024

KindlyMD(TM) to Participate in Upcoming October Conferences

KindlyMD(TM) Announces Contract with United Healthcare Insurance, the Largest Health Insurer in the United States

KindlyMD(TM) Announces $500,000 Share Repurchase Program

Contracts

KindlyMD(R) Announces New Partnership With Cigna Healthcare to Further Expand Patient Care Accessibility

KindlyMD(R) Announces Third Quarter 2024 Financial Results

American Shared Hospital Services Common Stock

American Shared Hospital

ATI Physical Therapy, Inc. Class A Common Stock

ATI Physical Therapy

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

CareMax

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group

Ontrak

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Psychemedics

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

Precipio

SHL Telemedicine Ltd - American Depositary Shares

Comments

Kindly MD

Kindly MD (KDLY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga